| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 49.66B | 49.47B | 46.64B | 45.56B | 43.12B | 40.37B |
| Gross Profit | 9.44B | 9.45B | 9.02B | 8.44B | 8.00B | 7.42B |
| EBITDA | 2.76B | 2.79B | 2.61B | 2.56B | 2.47B | 2.48B |
| Net Income | 1.83B | 1.92B | 1.88B | 2.10B | 1.63B | 1.72B |
Balance Sheet | ||||||
| Total Assets | 41.97B | 42.41B | 42.60B | 39.72B | 38.31B | 37.82B |
| Cash, Cash Equivalents and Short-Term Investments | 7.21B | 7.32B | 8.48B | 7.82B | 8.19B | 9.40B |
| Total Debt | 2.00B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 7.84B | 6.92B | 6.64B | 5.88B | 6.05B | 5.89B |
| Stockholders Equity | 34.13B | 35.49B | 35.96B | 33.84B | 32.27B | 31.93B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.67B | 1.52B | -56.67M | 335.60M | 3.17B |
| Operating Cash Flow | 0.00 | 2.67B | 2.52B | 686.42M | 1.02B | 3.33B |
| Investing Cash Flow | 0.00 | -1.75B | -1.11B | -445.56M | -880.96M | -225.54M |
| Financing Cash Flow | 0.00 | -2.08B | -706.52M | -604.35M | -1.35B | -1.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥48.00B | 5.27 | ― | 3.87% | 2.66% | -11.41% | |
73 Outperform | ¥53.65B | 13.47 | ― | 3.00% | 16.06% | 31.78% | |
71 Outperform | ¥28.20B | 8.61 | ― | 3.84% | 2.74% | 4.90% | |
66 Neutral | ¥29.02B | 12.14 | ― | 2.98% | -2.82% | 48.74% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥72.23B | 15.26 | ― | 3.17% | 5.95% | 23.97% | |
61 Neutral | ¥159.65B | 9.98 | ― | 2.42% | 9.74% | 6.48% |